| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $135K | -75.5% |
| Cost of Revenue | $123K | +339.3% |
| Gross Profit | $12K | -97.7% |
| R&D Expense | $11.0M | -11.9% |
| SG&A Expense | $7.3M | +2.7% |
| Operating Income | -$19.3M | +6.5% |
| Net Income | -$18.4M | +6.8% |
| EPS (Basic) | -$0.68 | +15.0% |
| EPS (Diluted) | -$0.68 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $25.8M | +104.7% |
| Short-term Investments | $995K | -85.7% |
| Accounts Receivable | $6K | — |
| Current Assets | $27.1M | +32.8% |
| Total Assets | $29.1M | +21.2% |
| Current Liabilities | $3.6M | -6.2% |
| Total Liabilities | $4.0M | -30.9% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$13.2M | +9.1% |
| Capital Expenditures | $14K | -54.8% |
| Investing Cash Flow | $6.1M | +190.1% |
| Financing Cash Flow | $20.3M | +60.0% |
| Free Cash Flow | -$13.3M | +9.2% |
| +15.0% |
| Stockholders' Equity |
| $25.1M |
| +38.0% |